RAC 2.10% $1.40 race oncology ltd

Ann: Annual General Meeting Presentation, page-16

  1. 1,254 Posts.
    lightbulb Created with Sketch. 496
    Given the actual FA potential of this drug and company(based on what i read), it shouldnt be up to shareholders support to progress the approval. Governments and WHO should step in to back this...
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.